NEUROTECH INTERNATIONAL LIMITED - Charts / Financials

7.69%

1.4¢

Market Cap $14.69M

Healthcare Biotechnology

Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical... Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical development company. The Company is focused predominately on pediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy called NTI164. It has completed a Phase II/III randomized, double-blind, placebo-controlled clinical trial in autism spectrum disorder (ASD) with clinically significant benefits reported across a number of clinically validated measures and safety. In addition, it has completed and reported significant and clinically meaningful Phase I/II trials in ASD and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS), collectively PANDAS/PANS along with Rett Syndrome. NTI164 is being developed as a therapeutic drug product for a range of neurological disorders in children where neuroinflammation is involved.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

REFRESH

Day
Open	1.3¢		Day High	1.4¢		Day Low	1.3¢
Daily Volume	307279

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
1	1.3¢	1917576		5	1.4¢	505017

Directors & Senior Management

Dr. Anthony Filippis	Chief Executive Officer, Managing Director, Executive Director
Dr. Alexandra Andrews	Chief Operating Officer
Mr. Gerald Quigley	Director of Public Relations, Non-Executive Director
Assoc. Prof. Carolyn Ellaway	Chief Medical Officer
Ms. Alessandra Gauvin	Company Secretary
Mr. Mark Davies	Non-Executive Chairman of the Board
Mr. Robert Maxwell Johnston	Non-Executive Director

Data source: Refinitiv

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.4¢		Change 0.001(7.69%)		Mkt cap ! $14.69M

Open	High	Low	Value	Volume
1.3¢	1.4¢	1.3¢	$4.026K	307.2K

Buyers (Bids)

No.	Vol.	Price($)
1	1917576	1.3¢

Sellers (Offers)

Price($)	Vol.	No.
1.4¢	505017	5

View Market Depth

No.	Vol.	Price($)
1	1917576	0.013
11	3680644	0.012
10	2248075	0.011
8	2120000	0.010
2	159000	0.009

Price($)	Vol.	No.
0.014	505017	5
0.015	1025224	4
0.016	689340	9
0.017	268623	2
0.018	563001	4

Last trade - 16.10pm 29/08/2025 (20 minute delay)

NTI (ASX) Chart

NEUROTECH INTERNATIONAL LIMITED - Charts / Financials

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories